We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ChemDiv and Siwa Biotech Announce Discovery Collaboration
News

ChemDiv and Siwa Biotech Announce Discovery Collaboration

ChemDiv and Siwa Biotech Announce Discovery Collaboration
News

ChemDiv and Siwa Biotech Announce Discovery Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ChemDiv and Siwa Biotech Announce Discovery Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ChemDiv, Inc. has announced the signing of a collaborative discovery research agreement with Siwa Biotech Corporation, Oklahoma City, OK.

Under the agreement, ChemDiv will be initiating a high-throughput screen for small molecule inhibitors of tyrosylprotein sulfotransferases. The collaboration provides Siwa Biotech with access to ChemDiv's expertise in chemistry systems and lead discovery. Financial terms of the collaboration were not disclosed.

"We are pleased that such a dynamic company as Siwa Biotech chose to work with ChemDiv team on this research program," said Dr. Ilya Okun, Vice President Biology and Chief Technology Officer at ChemDiv, Inc. "Over the years we have been continuously building upon our integrated services platform to provide our valued customers with strong and efficient support for all of their discovery and development needs."

"We are excited to initiate this collaborative discovery project with ChemDiv. The project has an excellent chance of success, based on ChemDiv's excellent track record in small molecule drug discovery," said Kevin L. Moore, M.D., President Siwa Biotech Corporation.

Advertisement